The Senate has commenced consideration of a bill that would expand the powers of the National Agency for Food and Drug Administration and Control (NAFDAC), giving it broader authority over product inspections, clinical trials, product recalls, post-market surveillance and the regulation of emerging health technologies.…
This story was indexed from the original publisher.
Read at The Sun